The evaluation of osteoconductive WE43 magnesium as a therapeutic approach for nonunion treatment
Alina Marie Schmitz, Judith Hahnemann, Katharina Schmidt-Bleek, Jakob Fenske, Agnes Ellinghaus, Denise Jahn, Heilwig Fischer, Georg Duda, Max Heiland, Carsten Rendenbach · 2026
Read The evaluation of osteoconductive WE43 magnesium as a therapeutic approach for nonunion treatment by Alina Marie Schmitz, Judith Hahnemann, Katharina Schmidt-Bleek, Jakob Fenske, Agnes Ellinghaus, Denise Jahn, Heilwig Fischer, Georg Duda, Max Heiland, Carsten Rendenbach (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13267517.txt.
Description
Alina Marie Schmitz and colleagues report a 2026 mouse study of a magnesium alloy for bones that fail to heal. Such nonunion breaks lack both bone growth and blood supply. The alloy, called WE43, slowly breaks down in the body and may spur bone and vessel growth. The team tested it in a standard thigh-bone nonunion model in mice.
Three groups were compared: the alloy alone, the alloy plus spongy bone graft, and graft alone. The alloy by itself healed poorly, with much bone-eating cell activity and scar-like tissue. The combined group shrank the defect, built more bone, and grew more small vessels, nearing graft-only results. Healing was checked at eight and twelve weeks. The authors say the alloy needs graft support to work.
Catalog record
| CREATOR | Alina Marie Schmitz, Judith Hahnemann, Katharina Schmidt-Bleek, Jakob Fenske, Agnes Ellinghaus, Denise Jahn, Heilwig Fischer, Georg Duda, Max Heiland, Carsten Rendenbach |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33255 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |